Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling.
Urban L, Novák Š, Čoma M, Dvořánková B, Lacina L, Šáchová J, Hradilová M, Svatoňová P, Kolář M, Strnad H, Březinová J, Smetana K Jr, Gál P, Szabo P. Urban L, et al. Among authors: gal p. Oncol Rep. 2024 Jan;51(1):3. doi: 10.3892/or.2023.8662. Epub 2023 Nov 17. Oncol Rep. 2024. PMID: 37975220 Free PMC article.
Complement MASP-1 Modifies Endothelial Wound Healing.
Németh Z, Demeter F, Dobó J, Gál P, Cervenak L. Németh Z, et al. Among authors: gal p. Int J Mol Sci. 2024 Apr 5;25(7):4048. doi: 10.3390/ijms25074048. Int J Mol Sci. 2024. PMID: 38612857 Free PMC article.
Impact of fibre supplementation on microbiome and resilience in healthy participants: A randomized, placebo-controlled clinical trial.
Eveleens Maarse BC, Eggink HM, Warnke I, Bijlsma S, van den Broek TJ, Oosterman JE, Caspers MPM, Sybesma W, Gal P, van Kraaij SJW, Schuren FHJ, Moerland M, Hoevenaars FPM. Eveleens Maarse BC, et al. Among authors: gal p. Nutr Metab Cardiovasc Dis. 2024 Feb 6:S0939-4753(24)00048-6. doi: 10.1016/j.numecd.2024.01.028. Online ahead of print. Nutr Metab Cardiovasc Dis. 2024. PMID: 38499450
A phase 1 trial of AP30663, a KCa2 channel inhibitor in development for conversion of atrial fibrillation.
Yfanti C, Vestbjerg B, Van't Westende J, Edvardsson N, Monfort LM, Olesen MS, Bentzen BH, Grunnet M, Eveleens Maarse BC, Diness JG, Kemme MJB, Sørensen U, Moerland M, van Esdonk MJ, Klaassen ES, Gal P, Holst AG. Yfanti C, et al. Among authors: gal p. Br J Clin Pharmacol. 2024 Apr;90(4):1027-1035. doi: 10.1111/bcp.15973. Epub 2024 Jan 8. Br J Clin Pharmacol. 2024. PMID: 37990600 Clinical Trial.
A Phase 1 randomized, open-label clinical trial to evaluate the effect of a far-infrared emitting patch on local skin perfusion, microcirculation and oxygenation.
van Kraaij SJW, Hamblin MR, Pickering G, Giannokopoulos B, Kechemir H, Heinz M, Igracki-Turudic I, Yavuz Y, Rissmann R, Gal P. van Kraaij SJW, et al. Among authors: gal p. Exp Dermatol. 2024 Jan;33(1):e14962. doi: 10.1111/exd.14962. Epub 2023 Nov 10. Exp Dermatol. 2024. PMID: 37950549 Clinical Trial.
467 results